2026 Southern Hemisphere Influenza Vaccine
Closed Solicitation Posted
A later notice was posted: the Limited / Sole Source Justification from .
- Solicitation number
- SPE2DP25R0004
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical Supply Chain is procuring 2026-2027 Southern Hemisphere Influenza Vaccine through solicitation SPE2DP-25-R-0004. The government seeks 6,000 packages containing 60,000 doses of 0.5 ML vaccines in pre-filled syringes, with the vaccine required to be FDA-approved, quadrivalent or trivalent, suitable for intramuscular administration for patients 6 months and older, and thimerosal-free. Key requirements include compliance with cold chain management protocols maintaining temperatures between 2-8°C, temperature monitoring during transit, F.O.B. destination pricing, and inspection at destination. The vaccine must be delivered to Defense Depot New Cumberland, Pennsylvania by March 16, 2026. The solicitation was posted on September 25, 2025, with a response deadline of October 10, 2025.
This procurement is set aside specifically for economically disadvantaged women-owned small business (EDWOSB) concerns, indicating it is not available for large business competition. The contract structure includes a guaranteed minimum quantity of 4,500 units with a maximum of 9,000 units, providing flexibility in ordering volumes. A separate line item accounts for the $0.75 per dose Federal Excise Tax that applies to these vaccines. The place of performance is the United States, with delivery required to the Defense Depot facility in New Cumberland, Pennsylvania. The annual estimated quantity is 6,000 packages, and the product will be non-returnable except for non-conforming vaccines which may be returned at the contractor's expense.
Notice text
2026 - 2027 Southern Hemisphere Influenza Vaccine Solicitation.
Files
| File | Type | Posted |
|---|---|---|
| SF1449_SPE2DP25R0004.PDF |
Notice history
| Notice | Type | Posted |
|---|---|---|
| 2026 Southern Hemisphere Influenza Vaccine | Limited / Sole Source Justification | |
| This notice | Solicitation | |
| 2026 Southern Hemisphere Influenza Vaccine | Pre-Solicitation | |
| 2026 Southern Hemisphere Influenza Vaccine | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & Response | Office of the Assistant Secretary for Preparedness and Response | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity